The Mayne Pharma Group Ltd (ASX: MYX) share price has fallen sharply today. MYX shares have fallen 7.6% to $0.85, after hitting a low of $0.81 earlier in the session.
Over the last 12 months, Mayne Pharma Group's shares have traded in a range of $0.81 to $2.11. That is, the shares are trading 59.7% below their 52-week high, achieved in August 2016.
Mayne Pharma Group is a pharmaceutical company, focused on applying its drug delivery expertise to commercialise branded and generic medicines, according to its website.
The shares have come under pressure this year, which can likely be attributed, in part, to allegations of drugs price-fixing in the United States, as well as concerns regarding the impact that President Trump's policies on generic drug prices could have on Mayne Pharma's sales.
According to the Australian Securities & Investments Commission, or ASIC, 11.6% of Mayne Pharma's shares were held as short positions as at 31 July 2017. That was up from approximately 7.4% at the beginning of the year.
